A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive ...

(Bloomberg) — Sandoz Group AG plans to launch a semaglutide generic drug in Canada when the patent for the main ingredient of blockbuster diabetic and weight-loss drugs like Ozempic and Wegovy ...

Cost (18 per cent) is the major reason identified in the survey, followed by not being covered by insurance (15 per cent), ...

LifeMD's Q2 earnings highlight mixed results and other issues, and the potential for high risk with high returns. Click here ...

In a recent study conducted by a team from The Ohio State University, US, it was revealed that a staggering 25% of adults, or ...

These drugs work to treat diabetes and weight loss by suppressing the appetite and lowering blood sugar and A1C—which may end ...

Vanda Pharmaceuticals’ shares were down more than 10% at $4.45 pre-market today, as the company provided an unfavorable ...

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be ...

Following a needed reinvention that resulted from the pandemic, there is now a seismic shift taking place in the fitness ...

Discover promising biotech candidates and groundbreaking research offering new hope for treating mitochondrial diseases.